The government will abandon price regulation on the Russian vital and essential drugs (VED) cost up to 50 rubles. As it became known to RBC, the Deputy Prime Minister Arkady Dvorkovich said in a letter to President Vladimir Putin. The representative of the Deputy Prime Minister Aliya Samigullina confirmed the authenticity of the letter.
The document Dvorkovich says that the government is considering a draft resolution that would allow pharmaceutical companies to coordinate with the health Ministry and the Federal Antimonopoly service price affordable medicines included in the EML. It also States that officials intend to maintain the subsidies pharmaceutical companies manufacturing these drugs. The new rules should enter into force before 1 January 2017.
As explained by the Director of development RNC Pharma Nikolay Bespalov, we are talking about such popular drugs from the list of essential drugs worth up to 50 rubles, as aspirin, ascorbic acid, glycine, Pancreatin, ibuprofen, water for injections. If the government will abandon price regulation, cost of, for example, glycine may increase from 23.5 to 49.9 RUB RUB.
In February, the pharmaceutical companies producing cheap medicines, announced the cessation of the manufacture of some medicines due to the fact that the cost of the drug in connection with the fall of the ruble and the need to procure substances for the production abroad has become higher than its total price. At the same time, Russian President Vladimir Putin gave the government the job to prevent the disappearance from the market of cheap domestic drugs included in essential drugs.
The Ministry announced that from April to December 2015 67 enterprises producing drugs worth up to 50 rubles to 500 rubles., 26 has temporarily suspended production of certain medications. All, by the end of December 2015, the market went 131 the drug is worth up to 50 rubles.
Under current law, manufacturers have the opportunity to re-register the price of essential drugs once a year taking into account inflation. The prices of these drugs sets the FAS. In the list for 2016 – 646 international non-proprietary names (INN), about 23.5 thousand brands.